Proteome and Phosphoproteome Analysis of Brown Adipocytes Reveals That RICTOR Loss Dampens Global Insulin/AKT Signaling

Mol Cell Proteomics. 2020 Jul;19(7):1104-1119. doi: 10.1074/mcp.RA120.001946. Epub 2020 Mar 31.

Abstract

Stimulating brown adipose tissue (BAT) activity represents a promising therapy for overcoming metabolic diseases. mTORC2 is important for regulating BAT metabolism, but its downstream targets have not been fully characterized. In this study, we apply proteomics and phosphoproteomics to investigate the downstream effectors of mTORC2 in brown adipocytes. We compare wild-type controls to isogenic cells with an induced knockout of the mTORC2 subunit RICTOR (Rictor-iKO) by stimulating each with insulin for a 30-min time course. In Rictor-iKO cells, we identify decreases to the abundance of glycolytic and de novo lipogenesis enzymes, and increases to mitochondrial proteins as well as a set of proteins known to increase upon interferon stimulation. We also observe significant differences to basal phosphorylation because of chronic RICTOR loss including decreased phosphorylation of the lipid droplet protein perilipin-1 in Rictor-iKO cells, suggesting that RICTOR could be involved with regulating basal lipolysis or droplet dynamics. Finally, we observe mild dampening of acute insulin signaling response in Rictor-iKO cells, and a subset of AKT substrates exhibiting statistically significant dependence on RICTOR.

Keywords: Phosphoproteome; adipocytes; insulin signaling; mTOR; phosphorylation; signal transduction; signaling circuits; targeted mass spectrometry.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes, Brown / drug effects*
  • Adipocytes, Brown / metabolism*
  • Animals
  • Chromatography, Liquid
  • Gene Knockout Techniques
  • Gene Ontology
  • Glycolysis / drug effects
  • Insulin / metabolism
  • Insulin / pharmacokinetics*
  • Lipogenesis / drug effects
  • Mechanistic Target of Rapamycin Complex 2 / metabolism*
  • Mice
  • Mitochondria / drug effects
  • Phosphorylation
  • Proteome / metabolism*
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Rapamycin-Insensitive Companion of mTOR Protein / genetics
  • Rapamycin-Insensitive Companion of mTOR Protein / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Tandem Mass Spectrometry

Substances

  • Insulin
  • Proteome
  • Rapamycin-Insensitive Companion of mTOR Protein
  • rictor protein, mouse
  • Mechanistic Target of Rapamycin Complex 2
  • Proto-Oncogene Proteins c-akt